MarketFoolery

Biogen falls 30% after halting trials for its Alzheimer’s drug. Healthcare analyst (and Industry Focus host) Shannon Jones discusses potential next moves for the suddenly-embattled pharmaceutical company. CVS starts selling cannabis products in eight states. Plus, a federal judge sides with the maker of Dum Dum lollipops in a battle against Tootsie Roll.

Get $50 off your first job post at www.LinkedIn.com/Fool.

Direct download: Market_Foolery_03_21_2019.mp3
Category:podcast -- posted at: 3:33pm EDT

1